CLINICAL EFFICACY TRIAL - THEOPHYLLINE VS (DL) 3,7-DIHYDRO-1,8-DIMETHYL-3-(2-METHYLBUTYL)-1H-PURINE-2,6-DIONE

Google Scholar
  • 1 January 1980
    • journal article
    • research article
    • Vol. 18  (12) , 518-522
Abstract
A synopsis of the results of a clinical efficacy trial involving a comparison of a new synthetic xanthine derivative (CK 0383) [(dl)-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione] and theophylline, with emphasis on the prevention of exercise-induced asthma (EIA) by both theophylline and the new drug, was presented. The results are preliminary, based on only 5 cases; study was continued as CK 0383 has a good bronchodilating activity without any important side effects.

This publication has 1 reference indexed in Scilit: